In this study, we demonstrate that conditional deletion of LSD1 in the myeloid lineage confers protection against inflammatory bone loss in two distinct murine models of osteolytic disease: LIP and K/BxN serum-transfer arthritis. This evidence concerns the gene KDM1A and Arthritis.